Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 261 - Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings
Patents for C07D 261 - Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings (11,459)
11/2008
11/04/2008US7446118 depression, anxiety, genitourinary diaorders, pain; monoamine reuptake inhibitors, triple and/or dual reuptake inhibitors of norepinephrine, serotonin, and dopamine; 5-(3-Methylamino-1H-phenyl-propyl)-1H-indole-3-carbonitrile
10/2008
10/30/2008WO2008130651A2 Diarylisoxazolines
10/30/2008WO2008130514A1 Substituted biphenyl phenoxy-, thiophenyl- and aminophenylpropanoic acid gpr40 modulators
10/30/2008US20080269280 Antiinflammatory agents; rheumatic diseases; multiple sclerosis
10/30/2008US20080269220 Antidiabetic agents; obesity; insulin resistance; neurodegenerative diseases; Alzheimer's disease
10/30/2008US20080269216 Gastrointestinal disorders; irritable bowel syndrome
10/30/2008US20080268509 Methods of labeling polynucleotides with energy transfer dyes
10/30/2008CA2685141A1 New compounds 806
10/29/2008EP1984340A1 Anthranilamide/2-amino-heteroarene carboxamide derivatives
10/29/2008CN101296908A Tricyclo substituted amides as glucokinase modulators
10/29/2008CN101296901A HIV-1 protease inhibitors, and methods of making and using them
10/29/2008CN100429214C Preparation of 1-aza-2-oxa-dibenzo [e,h] azulenes and their use for the manufacture of pharmaceutical formulations for the treatment and prevention of central nervous system diseases and disorders
10/28/2008US7442839 e.g. 4-{(1R)-2-[(6-{4-[3-(Cyclopentylsulfinyl)phenyl]butoxy}hexyl)amino]-1-hydroxyethyl}-2-(hydroxymethyl)phenol; beta 2-adrenoreceptor agonist; asthma, chronic obstructive pulmanory disease, bronchitis; antidepressant
10/28/2008US7442833 e.g. (2E)-3-(4-{(1Z)-2-phenyl-1-[4-(propionyloxy)phenyl]but-1-enyl}phenyl)prop-2-enoic acid; postmenopausal disorders, depressive symptoms; acylating anisole with 2-phenylbutanoic acid followed by demethylation, dehydration to yield phenol aldehyde, acylation and carboxylation to yield ester prodrug
10/28/2008US7442802 e.g. 1-(1-cyclohexyl-5-(4-(methylsulfonyl)phenyl)pyrazol-3-yl)-4-hydroxybutan-1-one; antiinflammatory agent, analgesic, antipyretic, wound healing agents; gastrointestinal disorders; side effect reduction
10/28/2008US7442702 Prostaglandin agonists
10/23/2008WO2008126772A1 Therapeutic agent for hypertension
10/23/2008WO2008126665A2 Isoxazoline compounds and their use in pest control
10/23/2008WO2008125014A1 Urea compounds, preparation methods and pharmaceutical uses thereof
10/23/2008WO2008035315A9 Inhibitors of phosphodiesterase type-iv
10/23/2008US20080262057 pesticides
10/23/2008US20080262048 Control of parasites in animals by the use of novel trifluoromethanesulfonanilide oxime ether derivatives
10/23/2008US20080261994 4-[5-((1S,2R)-1-Carboxy-2-phenyl-cyclopropylsulfamoyl)-thiophen-2-yl]-3,6-dihydro-2H-pyridine-1-carboxylic acid tert-butyl ester; aggrecanase and matrix metalloproteinase (with zinc in the catalytic active center) inhibitor; antiarthritic agent: osteoarthritis, rheumatoid arthritis
10/22/2008EP1981866A1 Fungicide n-cycloalkyl-benzyl-amide derivatives
10/22/2008EP1981858A2 3,5-di(aryl or heteroaryl)isoxazoles and 1,2,4-oxadiazoles as s1p1 receptor agonists, immunosuppresssive and anti-inflammatory agents
10/22/2008EP1981837A2 Methods and compositions for modulating sphingosine-1-phosphate (s1p) receptor activity
10/22/2008EP1667647A4 Monocyclic and bicyclic lactams as factor xa inhibitors
10/16/2008WO2008123469A1 Six-membered amide compound and use thereof
10/16/2008WO2008123349A1 Method for producing n-phenyl-n'-phenylsulfonylpiperazine derivative
10/16/2008WO2008122787A1 Piperazine compounds for the inhibition of haematopoietic prostaglandin d synthase
10/16/2008WO2008122357A1 5-oxo-isoxazoles as inhibitors of lipases and phospholipases
10/16/2008US20080255221 Novel hydroxamates as therapeutic agents
10/16/2008US20080255214 Novel hydroxamates as therapeutic agents
10/16/2008US20080255202 Phenylthioacetic Acid Derivatives and Use Thereof
10/16/2008US20080255194 1-(4-(3-(4-(6-fluorobenzo[d]isoxazol-3-yl)piperidin-1-yl)propoxy)-3-methoxy-d3-phenyl)ethanone substituted with deuterium ions; antipsycholtic agent
10/16/2008US20080255182 Certain chemical entities, compositions, and methods
10/16/2008US20080255133 N-(2-aylamino)aryl sulfonamides such as N-(7-(4-bromo-2-fluorophenylamino)imidazo[1,2-b]pyridazin-6-yl)-1-(2-hydroxyethyl)cyclopropane-1-sulfonamide; mitogen-activated ERK activating kinase (MEK) inhibitors; antiproliferative, anticarcinogenic, and antiinflammatory agents
10/16/2008US20080255095 Benzylamine analogues
10/16/2008US20080255078 Menopausal or postmenopausal disorders, vasomotor symptoms, urogenital disorders, female sexual dysfunction, breast cancer, depression, diabetes, bone demineralization, and osteoporosis; carboxy or hydroxyalkoxyalkoxy-group-substituted phenyl at position 2 of 1,1,2-triphenylethylene compounds
10/16/2008CA2683180A1 Insecticidal aryl isoxazoline derivatives
10/16/2008CA2682891A1 5-oxoisoxazoles as inhibitors of lipases and phospholipases
10/15/2008EP1979322A1 Cyclohexyl sulfonamide derivatives having h3 receptor activity
10/15/2008EP1692124B1 Biaryl sulfonamides as mmp inhibitors
10/14/2008US7435843 Thiobenzoic acid, N-malonylhydrazide in which the free carboxy group is protected; enhances the desirable tumor attacking properties of anticancer agents without further increasing undesirable side-effects
10/14/2008CA2309328C Cyclic amine derivatives and their use as drugs
10/09/2008WO2007092285A3 Treatment of synucleinopathies
10/09/2008US20080249139 N-((1S,2R)-1-(3,5-difluorobenzyl)-3-{[(1S)-7-ethyl-1,2,3,4-tetrahydronaphthalen-1-yl]amino}-2-hydroxypropyl)pyrazine-2-carboxamide for example; or corresponding sulfonamides; beta-secretase inhibitors; dementia; Alzheimer's disease
10/09/2008US20080249102 Hiv Protease Inhibitors
10/08/2008EP1977749A1 Use of cyclooxygenase-2 inhibitors in the treatment and prevention of neoplasia
10/08/2008EP1976840A1 Cyclohexyl piperazinyl methanone derivatives and their use as histamine h3 receptor modulators
10/08/2008EP1976837A1 Dicarbonylic compounds with antibacterial activity
10/08/2008EP1606283B1 P38 inhibitors and methods of use thereof
10/08/2008EP1283042B1 Aqueous liquid preparation of pranoprofen
10/07/2008US7432293 Heterocyclic compounds useful as Nurr-1 activators
10/07/2008US7432289 5-Acylamino-1,1′-biphenyl-4-carboxamide derivatives and their use as P38 kinase inhibitors
10/07/2008US7432287 e.g. 3-(6-ethanesulfonylpyridin-3-yloxy)-5-(2-hydroxy-1-methyl-ethoxy)-N-(1-methyl-1H-pyrazol-3-yl)benzamide; glucokinase activator; antidiabetic agent; obesity, insulin resistance
10/07/2008US7432285 Nitrosated and nitrosylated cyclooxygenase-2 inhibitors, compositions and methods of use
10/07/2008US7432058 Non-nucleosidic linker linking xanthene donor to 4,7-dichlororhodamine acceptor;
10/07/2008CA2416685C Oxygenated esters of 4-iodo phenylamino benzhydroxamic acids
10/02/2008WO2008116663A2 Heterocyclyl-substituted-tetrahydro-naphthalen-amine derivatives, their preparation and use as medicaments
10/02/2008US20080242702 Paclitaxel enhancer compound
10/02/2008US20080242656 N-Substituted-N-Sulfonylaminocyclopropane Compounds and Pharmaceutical Use Thereof
10/02/2008CA2682163A1 Heterocyclyl-substituted-tetrahydro-naphthalen-amine derivatives, their preparation and use as medicaments
10/01/2008EP1975161A1 Heterocyclyl-substituted- tetrahydro-napthalen-amine derivatives, their preparation and use as medicaments
10/01/2008EP1973888A1 Isoxazolines for controlling invertebrate pests
10/01/2008EP1372655B1 Cathepsin cysteine protease inhibitors
10/01/2008CN101277939A Acyclic ikur inhibitors
10/01/2008CN101274915A Method for synthesizing isoxazole
09/2008
09/30/2008US7429603 C-fms kinase inhibitors
09/30/2008US7429588 Crystalline isoxazole derivative and medical preparation thereof
09/30/2008CA2303848C Substituted anilides
09/25/2008WO2008115149A1 N-HETEROCYCLIC CARBENE CATALYZED SYNTHESIS OF N-PHENYLISOXAZOLIDIN-5-ONE DERIVATIVE AND SYNTHESIS OF β -AMINO ACID ESTER DERIVATIVE
09/25/2008US20080234293 Tri-aryl/heteroaromatic cannabinoids and use thereof
09/25/2008US20080234281 2,3-Dihydrooxadiazoles such as 3-acetyl-5-(2,5-difluorophenyl)-2-phenyl-2,3-dihydro-1,3,4-oxadiazole and 3-[3-acetyl-5-(2,5-difluorophenyl)-2-phenyl-2,3-dihydro-1,3,4-oxadiazol-2-yl]-N,N-dimethylpropan-1-amine that are useful for treating cancer
09/25/2008US20080234199 Chemical Compounds
09/25/2008US20080233102 administering a transglutaminase inhibitor, particularly a compound with a 3-halo-dihydroisoxazole moiety or an analog of isatin, to attenuate gluten toxicity
09/24/2008CN101270069A Synthesis of taxol enhancers
09/17/2008CN101268041A Sulphonamide derivatives
09/17/2008CN100418951C Cycloamine derivative and its use as medicine
09/16/2008US7425554 1,2-di(cyclic)substituted benzene compounds
09/12/2008WO2008109334A1 Novel crystalline salt form of an antidiabetic compound
09/12/2008WO2008109027A2 Tri-aryl/heteroaroaromatic cannabinoids and use thereof
09/12/2008WO2008108448A1 Isoxazoline-substituted benzamide compound and pest control agent
09/12/2008WO2004078116A9 P38 inhibitors and methods of use thereof
09/11/2008US20080220057 Therapeutic compounds and methods of use
09/10/2008EP1966170A2 Estrogen modulators
09/10/2008EP1965805A1 Urea derivatives useful as calcium receptor modulators
09/10/2008EP1965644A1 Novel herbicides
09/10/2008EP1437349B9 Substituted isoxazoles and the use thereof as antibiotics
09/10/2008CN101263128A Method for sulfonation of 1,2-benzisoxazole-3-acetic acid
09/09/2008US7423147 Therapy of Histamine H3 receptor mediated diseases
09/09/2008US7423140 An acceptor fluorophore efficiently absorbs energy emission of a linked donor xanthene fluorophore labelling a oligonucleotide primer, reagent for sequencing nucleic acids, DNA sequencing
09/09/2008CA2211646C Substituted phenyl compounds as endothelin antagonists
09/04/2008WO2008104994A2 2,2,2-tri-substituted acetamide derivatives as glucokinase activators, their process and pharmaceutical application
09/04/2008US20080214655 Paclitaxel or a paclitaxel analog and 2,5-Dimethoxythiobenzoic acid N-methylhydrazine; antitumor; nontoxic
09/04/2008US20080214636 antiinflammatory, analgesic, antiallergic, cough-preventing, liver-protecting and anti-viral properties; side effects reduction; N-[(3-p-hydroxylphenyl-isoxazol-5-yl)methyl]-glycyrrhetinamide
09/04/2008US20080214546 N-hydroxyamidinoheterocycles as modulators of indoleamine 2,3-dioxygenase
09/04/2008US20080214448 Compounds, Methods and Formulations for the Oral Delivery of a Glucagon-Like Peptide (Glp)-1 Compound or a Melanocortin-4 Receptor (Mc4) Agonist Peptide
09/04/2008US20080213822 Methods for diagnosing celiac sprue and reagents useful therein
09/04/2008US20080213427 Administering glutenase to Celiac or dermatitis herpetiformis patient reduces levels of toxic gluten oligopeptides
1 ... 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 ... 115